The Food and Drug Administration (FDA) has reported that Hexabrix (ioxaglate meglumine, ioxaglate sodium; Guerbet LLC), a medical imaging agent.. Hexabrix is a radiopaque contrast medium indicated ...

Publish Date January 15, 2007 . Kidney Int. 2006;70:1811-1817 ...

In patients with chronic kidney disease undergoing cardiac catheterization, the use of an ionic low-osmolar contrast medium appears to yield numerically lower mortality compared with use of a ...